Product Pipeline

Pre-Clinical >

Phase I >

Phase II >

Phase III >

Regulatory Review >

Approved >

Market

KUB-018

Nail Fungus
Exclusive Canadian Licence Rights
MORE DETAILS

Phase III

SUF-201

Moderate to severe plaque psoriasis
Exclusive Canadian Licence Rights
MORE DETAILS
Phase III

ETR-101

Tattoo removal
Global Product Rights
MORE DETAILS

Pre-Clinical

©2025 Treata Pharma Corporation
All Rights Reserved.

Treata Pharma Corporation
170 University Avenue, Suite 602
Toronto, ON M5H 3B3
Phone: (905) 693-8285